MDI Health offers an autonomous, hyper-personalized AI medication management platform that analyzes thousands of factors to identify medication-related risks and provides recommendations in minutes instead of hours. The platform equips clinicians, payers and pharmacies to perform comprehensive medication reviews, reduce adverse drug events and improve outcomes. MDI positions its solution as an alternative to alert-based medication management tools that require laborious processes. The company cites medication-related harms as a major driver of costs and mortality and targets cost savings and improved health outcomes at scale. MDI plans to use new funding to meet rising customer demand and to scale its U.S. and Israeli R&D teams to drive product development. The company was founded in 2019 and is based in Los Angeles; its disclosures state U.S. medication-related costs total $528 billion annually.

Total raised

$20M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2023